Nurix Therapeutics
NRIX
22.73
+0.13
+0.58%
Nurix Therapeutics
US · NRIX
#2679 by market cap
Listed 2020
22.73
+0.13
+0.58%
Live - 5344 symbols - heartbeat 385s ago
· 2026-10-08 07:00
Pre-market
22.73
0.00%
After-hours
22.73
0.00%
- Market cap
- 2.36B
- P/E (TTM)i
- -6.57
- P/Bi
- 5.86
- EPSi
- -3.05
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on NRIX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
34.50 +51.8%
Price target rangecurrent 22.73
Low25.00
Avg34.50
High45.00
Buy 90%
Hold 10%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-10 | RBC Capital | -- | BUY | 36.00 |
| 2026-08-04 | Needham | -- | BUY | 34.00 |
| 2026-07-28 | Morgan Stanley | -- | BUY | 38.00 |
| 2026-07-27 | Morgan Stanley | -- | BUY | 38.00 |
| 2026-07-22 | UBS | -- | BUY | 31.00 |
| 2026-07-14 | Wells Fargo | -- | HOLD | 25.00 |
| 2026-07-10 | Truist Financial | -- | BUY | 34.00 |
| 2026-07-10 | Stifel | -- | BUY | 40.00 |
| 2026-07-10 | Needham | -- | BUY | 34.00 |
| 2026-07-10 | H.C. Wainwright | -- | BUY | 34.00 |
| 2026-07-10 | Oppenheimer | -- | BUY | 28.00 |
| 2026-07-09 | RBC Capital | -- | BUY | 33.00 |
| 2026-07-08 | Jefferies | -- | BUY | 45.00 |
| 2026-07-01 | BTIG | -- | BUY | 32.00 |
| 2026-06-29 | Oppenheimer | -- | BUY | 28.00 |
| 2026-06-15 | Jefferies | -- | BUY | 45.00 |
| 2026-06-15 | Stifel | -- | BUY | 34.00 |
| 2026-06-15 | Needham | -- | BUY | 34.00 |
| 2026-06-11 | BTIG | -- | BUY | 32.00 |
| 2026-06-11 | H.C. Wainwright | -- | BUY | 32.00 |
| 2026-06-11 | J.P. Morgan | -- | BUY | -- |
| 2026-06-10 | H.C. Wainwright | -- | BUY | 32.00 |
| 2026-06-09 | Wells Fargo | -- | HOLD | 25.00 |
| 2026-06-09 | BTIG | -- | BUY | 32.00 |
| 2026-06-09 | Truist Financial | -- | BUY | 32.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 1
■ Upgrades■ Downgrades
- 1 upgrade vs 1 downgrade among tracked analyst rating changes.
- Most recent: Wells Fargo moved from Buy to Hold on 2026-06-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-08 | Wells Fargo | BUY → HOLD | 25.00 |
| 2026-01-08 | Morgan Stanley | HOLD → BUY | 36.00 |
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.